Johannes Atta

Giessen, HE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

How to optimize the CAR-T Cell therapy process? A group concept mapping analysis of preconditions for a frictionless process from a German multistakeholder perspective.

How to optimize the CAR-T Cell therapy process? A group concept mapping analysis of preconditions for a frictionless process from a German multistakeholder perspective.

Journal: Frontiers in oncology

Published: July 18, 2024

The mTOR Inhibitor Temsirolimus Added to Rituximab Combined With Dexamethasone, Cytarabine, and Cisplatinum (R-DHAP) for the Treatment of Patients With Relapsed or Refractory DLBCL - Results From the Phase-II STORM Trial.

The mTOR Inhibitor Temsirolimus Added to Rituximab Combined With Dexamethasone, Cytarabine, and Cisplatinum (R-DHAP) for the Treatment of Patients With Relapsed or Refractory DLBCL - Results From the Phase-II STORM Trial.

Journal: HemaSphere

Published: April 02, 2021

Final Results of a Phase I/II Trial of the Combination Bendamustine and Rituximab With Temsirolimus (BeRT) in Relapsed Mantle Cell Lymphoma and Follicular Lymphoma.

Final Results of a Phase I/II Trial of the Combination Bendamustine and Rituximab With Temsirolimus (BeRT) in Relapsed Mantle Cell Lymphoma and Follicular Lymphoma.

Journal: HemaSphere

Published: February 13, 2020

Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase-I trial.

Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase-I trial.

Journal: British journal of haematology

Published: October 09, 2018

Myelodysplastic syndrome, acute leukemia and stem cell transplantation

Myelodysplastic syndrome, acute leukemia and stem cell transplantation

Journal: Zeitschrift fur Rheumatologie

Published: January 14, 2018

Title Not Found

Title Not Found

Journal: Zeitschrift fur Rheumatologie

Published: October 04, 2017

Resection of central nervous system lymphoma: a paradigm shift?

Resection of central nervous system lymphoma: a paradigm shift?

Journal: Journal of neurosurgical sciences

Published: September 30, 2016

High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study).

High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study).

Journal: Leukemia

Published: August 25, 2016

Safety and efficacy of Temsirolimus in combination with Bendamustine and Rituximab in relapsed mantle cell and follicular lymphoma.

Safety and efficacy of Temsirolimus in combination with Bendamustine and Rituximab in relapsed mantle cell and follicular lymphoma.

Journal: Leukemia

Published: November 26, 2014

Autologous stem cell transplantation in HIV-related lymphoma in the rituximab era - a feasibility study in a monocentric cohort.

Autologous stem cell transplantation in HIV-related lymphoma in the rituximab era - a feasibility study in a monocentric cohort.

Journal: Journal of the International AIDS Society

Published: November 14, 2014

Prophylactic use of pegfilgrastim in patients treated with a nitrosourea and teniposide for recurrent glioma.

Prophylactic use of pegfilgrastim in patients treated with a nitrosourea and teniposide for recurrent glioma.

Journal: Pharmacotherapy

Published: March 13, 2014

Successful treatment of AIDS-associated, primary CNS lymphoma with rituximab- and methotrexate-based chemotherapy and autologous stem cell transplantation.

Successful treatment of AIDS-associated, primary CNS lymphoma with rituximab- and methotrexate-based chemotherapy and autologous stem cell transplantation.

Journal: Infection

Published: October 11, 2013

Showing 1-12 of 14

Last Updated: 09/26/2026